Biomedical Engineering Reference
In-Depth Information
16. Aiba S. Studies on chitosan: 4. Lysozymic hydrolysis of partially N-acetylated
chitosans
. Int J. Biol. Macromol.
1992; 14: 225-228.
17. Gao Qun, Wan Ajun, Zhang Yong Ef ect of reacetylation and degradation
on the chemical and crystal structures of chitosan.
J. Appl. Polym. Sci.
2007;
104: 2720-2728.
18. Kulish EI, Fatkullina RR, Volodina VP, Kolesov SV, Monakov YB. Enzymatic
degradation of modii ed chitosan i lms. Russ.
J. Appl. Chem.
, 2007, 80
1178-1180.
19. Ren D, Yi H, Wang W, Ma X. h e enzymatic degradation and swelling proper-
ties of chitosan matrices with dif erent degrees of N-acetylation.
Carbohydr.
Res.
2005; 340: 2403-2410.
20. Hjerde RJN, Varum KM, Grasdalen H, Tokura S, Smidsrod O. Chemical
composition of O-(carboxymethyl)- chitins in relation to lysozyme degrada-
tion rates.
Carbohydr. Polym.
1997; 34: 131-139.
21. Lee KY, Ha WS, Park WH. Blood compatibility and biodegradability of par-
tially N-acylated chitosan derivatives.
Biomaterials
1995; 16: 1211-1216.
22. Feng T, Gong J, Du, Y, Huang Z. Free radical scavenging activity of cellulase-
treated chitosan
. J. Appl. Polym. Sci.
2009; 111: 545-550.
23. Qin C, Du Y, Zong L, Zeng F, Liu Y, Zhou B. Ef ect of hemicellulase on the
molecular weight andstructure of chitosan.
Polym. Degrad. Stab
. 2003; 80:
435-441.
24. Kumar ABV, Varadaraj MC, Gowda LR, h aranathan RN. Characterization
of chitooligosaccharides prepared by chitosanolysis with the aid of papain
and pronase, and their bactericidal action against Bacillus cereus and
Escherichia coli.
Biochem. J.
2005; 391: 167-175.
25. Lee D-X. Xia W-S, Zhang J-L. Enzymatic preparation of chitooligosaccha-
rides by commercial lipase
. Food Chem.
2008; 111: 291-299.
26. Kulish EI, Volodina VP, Kolesov SV, Zaikov GE. Enzymatic degradation of
chitosan i lms by collagenase.
Polym. Sci. Ser. B
2006, 48: 244-246.
27. Wadstein J, h om E, Heldman E, Gudmunsson S, Lilja B.
Biopolymer
L112, a
chitosan with fat binding properties and potential as a weight reducing agent.
In:
Chitosan Per OS From Dietary Supplement to Drug Carrier
(Muzzarelli
RAA Ed) 2000, Grottammare: Atec, pp. 65-76.
28. Arai K, Kinumaki T, Fujita T. Toxicity of chitosan.
Bull Tokai Reg Fish Lab
1968; 43: 89-94.
29. Mita Y. Character of chitosan and its application to cosmetics. In:
Development
and application of chitin and chitosan.
(Shinada T. Ed) 1987, Kogyo-gijyutsu-
kai: Tokyo, pp. 248-269.
30. Dornish M, Hagen A, Hanson E, Percheur C, Verdier F, Skaugrud O. Safety
of Protasan:ultrapure chtosan salts for biomedical and pharmaceutical use.
Adv. Chitin Sci.
1997; 2: 664-670.
31. Hirano S, Iwata M, Yamanaka K, Tanaka H, Toda T, Inui H. Enhancement of
serum lysozyme activity by injecting a mixture of chitosan oligosaccharides
intravenously in rabbits. Agricult
. Biol. Chem.
1991; 55: 2623-2625.
